awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41001091-3F4E4679-04A2-4945-A49F-61DCF67413D4
Q41001091-3F4E4679-04A2-4945-A49F-61DCF67413D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41001091-3F4E4679-04A2-4945-A49F-61DCF67413D4
Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial.
P2860
Q41001091-3F4E4679-04A2-4945-A49F-61DCF67413D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41001091-3F4E4679-04A2-4945-A49F-61DCF67413D4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a657e1cd9e5a1f101512a78ad109d44295bc48e
P2860
Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.